or
forgot password

    • cancer clinical trials in tennessee

    • Chemotherapy Toxicity Reduction Via Urea Cycle Support
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Cancer
    S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
    H. Clay Evans Johnson Cancer Center at Memorial Hospital

    Trial Locations
    H. Clay Evans Johnson Cancer Center at Memorial Hospital
    U.T. Cancer Institute at University of Tennessee Medical Center
    Pancreatic Cancer
    Radiation Therapy in Treating Young Patients With Gliomas
    East Tennessee Children's Hospital

    Trial Locations
    East Tennessee Children's Hospital
    St. Jude Children's Research Hospital
    Brain Tumor, Central Nervous System Tumor
    Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
    Chattanooga Oncology and Hematology Assoicates, PC

    Trial Locations
    Chattanooga Oncology and Hematology Assoicates, PC
    Sarah Cannon Research Institute
    Breast Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Erlanger Health Systems

    Trial Locations
    Erlanger Health Systems
    The Jones Clinic
    Jackson-Madsion County Hosp
    Clopton Clinic
    Sarah Cannon Cancer Center
    Vanderbilt University Medical
    Non-Small Cell Lung Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Chattanooga Gynecological Oncology

    Trial Locations
    Chattanooga Gynecological Oncology
    East Tennessee State University
    Vanderbilt University
    Meharry Medical College
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    East Tennessee State University

    Trial Locations
    East Tennessee State University
    Knoxville Gynecologic Cancer Specialists PC
    University of Tennesee Health Science Center
    Vanderbilt University
    Meharry Medical College
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Thompson Cancer Survival Center

    Trial Locations
    Thompson Cancer Survival Center
    University of Tennessee Cancer Institute - Memphis
    MBCCOP - Meharry Medical College - Nashville
    Colorectal Cancer
    Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis
    Vanderbilt Children's Hospital
    Nashville, Tennessee 37232-6310
    Childhood Langerhans Cell Histiocytosis
    Gemcitabine and/or Erlotinib as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Kingsport Hematology-Oncology Associates

    Trial Locations
    Kingsport Hematology-Oncology Associates
    University of Tennessee Cancer Institute - Memphis
    Lung Cancer
    Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Prostate Cancer
    Enzastaurin Versus Lomustine in Glioblastoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Memphis, Tennessee 38138
    Glioblastoma
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    University of Tennessee Medical Center

    Trial Locations
    University of Tennessee Medical Center
    Vanderbilt University
    Melanoma
    A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma
    Vanderbilt University Medical Center Dept. of Cancer Center
    Nashville, Tennessee 37232
    Metastatic Melanoma
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    MBCCOP - Meharry Medical College - Nashville
    Nashville, Tennessee 37208-3599
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    MBCCOP - Meharry Medical College - Nashville
    Nashville, Tennessee 37208-3599
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Blue Ridge Medical Specialists PC

    Trial Locations
    Blue Ridge Medical Specialists PC
    Erlanger Medical Center
    Cookeville Regional Medical Center
    Vanderbilt-Ingram Cancer Center Cool Springs
    Jones Clinic
    Jackson-Madison County General Hospital
    The Jackson Clinic PA
    Wellmont Holston Valley Hospital and Medical Center
    Thompson Cancer Survival Center
    The Center for Biomedical Research
    East Tennessee Baptist Hospital-Mercy Health Partners
    University of Tennessee - Knoxville
    University of Tennessee - Memphis
    Baptist Hospital
    Vanderbilt University
    Meharry Medical College
    Tennessee Oncology PLLC- Centennial Medical Center
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer